GLSI
Greenwich Lifesciences Inc
NASDAQ: GLSI · HEALTHCARE · BIOTECHNOLOGY
$21.60
-5.26% today
Updated 2026-04-29
Market cap
$332.37M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.46
Dividend yield
—
52W range
$8 – $34
Volume
0.2M
Greenwich Lifesciences Inc (GLSI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-120847.00 | $-114952.00 | $-293267.00 | $-1.15M | $-4.29M | $-6.20M | $-6.48M | $-7.27M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.00 | $0.00 | $3.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $194943.00 | $677988.00 | $660582.00 | $1.74M | $2.38M | $7.25M |
| Free cash flow | $-120847.00 | $-114952.00 | $-293267.00 | $-1.15M | $-4.29M | $-6.20M | $-6.48M | $-7.27M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $28.65M | $-1.46M | — | — | — |